Frequency of sarcopenia and efficacy of levo carnitine(We change it to Levocarnitine from May 15, 2015) in patients with liver cirrhosis

Frequency of sarcopenia and efficacy of levo carnitine(We change it to Levocarnitine from May 15, 2015) in patients with liver cirrhosis - Frequency of sarcopenia and efficacy of levo carnitine in patients with liver cirrhosis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014100

Enrollment

100

Registered

2014-05-30

Start date

2014-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cirrhosis

Interventions

levo carnitine chloride 1800 mg/day lifestyle intervention(We change it to Lebocarnitine 1500mg/day from May 15, 2015) lifestyle intervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients who clinically diagnosed as liver cirrhosis

Exclusion criteria

Exclusion criteria: patients with pacemaker patients with metal in their body

Design outcomes

Primary

Measure	Time frame
efficacy of levo carnitine chloride(We change it to Levocarnitine from May 15, 2015)	—

Countries

Japan

Contacts

Public ContactOsamu Kurai

Osaka City Juso Hospitcal Department of Gastroenterology

kuraion2@gmail.com06-6150-8000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026